Metastatic Thymic Carcinoma
Also known as: Metastatic thymic carcinoma (morphologic abnormality)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00958 | Carboplatin | 2 | Active Not Recruiting | 1 |
| DB09078 | Lenvatinib | 2 | Active Not Recruiting | 1 |
| DB06599 | Lexatumumab | 2 | Active Not Recruiting | 1 |
| DB01229 | Paclitaxel | 2 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Active Not Recruiting | 1 |
| DB05578 | Ramucirumab | 2 | Active Not Recruiting | 1 |